129 related articles for article (PubMed ID: 35716470)
1. Ginsenoside Rb1 prevents osteoporosis via the AHR/PRELP/NF-κB signaling axis.
Zhang D; Du J; Yu M; Suo L
Phytomedicine; 2022 Sep; 104():154205. PubMed ID: 35716470
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats.
Bei J; Zhang X; Wu J; Hu Z; Xu B; Lin S; Cui L; Wu T; Zou L
PLoS One; 2018; 13(9):e0202885. PubMed ID: 30212470
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rb1 attenuates microglia activation to improve spinal cord injury via microRNA-130b-5p/TLR4/NF-κB axis.
Wang D; Zhao S; Pan J; Wang Z; Li Y; Xu X; Yang J; Zhang X; Wang Y; Liu M
J Cell Physiol; 2021 Mar; 236(3):2144-2155. PubMed ID: 32761843
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TRG-AS1 protects against glucocorticoid-induced osteoporosis in a rat model by regulating miR-802-mediated CAB39/AMPK/SIRT-1/NF-κB axis.
Liu W; Li G; Li J; Chen W
Hum Cell; 2022 Sep; 35(5):1424-1439. PubMed ID: 35794445
[TBL] [Abstract][Full Text] [Related]
5. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway.
Zhou S; Lu S; Guo S; Zhao L; Han Z; Li Z
J Biomed Nanotechnol; 2021 Oct; 17(10):2085-2098. PubMed ID: 34706808
[TBL] [Abstract][Full Text] [Related]
7. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia.
Zhu J; Jiang Y; Wu L; Lu T; Xu G; Liu X
Neuroscience; 2012 Jan; 202():342-51. PubMed ID: 22173011
[TBL] [Abstract][Full Text] [Related]
8. PRELP (proline/arginine-rich end leucine-rich repeat protein) promotes osteoblastic differentiation of preosteoblastic MC3T3-E1 cells by regulating the β-catenin pathway.
Li H; Cui Y; Luan J; Zhang X; Li C; Zhou X; Shi L; Wang H; Han J
Biochem Biophys Res Commun; 2016 Feb; 470(3):558-562. PubMed ID: 26809092
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 protects hippocampal neurons in depressed rats based on mitophagy-regulated astrocytic pyroptosis.
Li Y; Li J; Yang L; Ren F; Dong K; Zhao Z; Duan W; Wei W; Guo R
Phytomedicine; 2023 Dec; 121():155083. PubMed ID: 37722244
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE₂ production in a human keratinocyte cell line HaCaT.
Huang J; Qiu L; Ding L; Wang S; Wang J; Zhu Q; Song F; Hu J
Int Immunopharmacol; 2010 Oct; 10(10):1279-83. PubMed ID: 20678598
[TBL] [Abstract][Full Text] [Related]
11. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.
Rucci N; Rufo A; Alamanou M; Capulli M; Del Fattore A; Ahrman E; Capece D; Iansante V; Zazzeroni F; Alesse E; Heinegård D; Teti A
J Cell Biol; 2009 Nov; 187(5):669-83. PubMed ID: 19951916
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rb1 promotes the activation of PPARα pathway via inhibiting FADD to ameliorate heart failure.
Li C; Zhang X; Li J; Liang L; Zeng J; Wen M; Pan L; Lv D; Liu M; Cheng Y; Huang H
Eur J Pharmacol; 2023 May; 947():175676. PubMed ID: 37001580
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats.
Yuan QL; Yang CX; Xu P; Gao XQ; Deng L; Chen P; Sun ZL; Chen QY
Brain Res; 2007 Sep; 1167():1-12. PubMed ID: 17663984
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway.
Li CY; Yang P; Jiang YL; Lin Z; Pu YW; Xie LQ; Sun L; Lu D
Biomed Pharmacother; 2020 May; 125():109913. PubMed ID: 32006902
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways.
Cheng B; Li J; Du J; Lv X; Weng L; Ling C
Food Chem Toxicol; 2012 May; 50(5):1610-5. PubMed ID: 22386813
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1 retards aging process by regulating cell cycle, apoptotic pathway and metabolism of aging mice.
Yu S; Xia H; Guo Y; Qian X; Zou X; Yang H; Yin M; Liu H
J Ethnopharmacol; 2020 Jun; 255():112746. PubMed ID: 32165173
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rb1 improves energy metabolism in the skeletal muscle of an animal model of postoperative fatigue syndrome.
Tan SJ; Li N; Zhou F; Dong QT; Zhang XD; Chen BC; Yu Z
J Surg Res; 2014 Oct; 191(2):344-9. PubMed ID: 24881470
[TBL] [Abstract][Full Text] [Related]
18. Casticin promotes osteogenic differentiation of bone marrow stromal cells and improves osteoporosis in rats by regulating nuclear factor-κB/mitogen-activated protein kinase.
Zhang D; Li X; Li J; Liu W; Yu Y; Wang S; Ye X
Int J Rheum Dis; 2023 Jan; 26(1):80-87. PubMed ID: 36195975
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model.
Yang T; Miao Y; Zhang T; Mu N; Ruan L; Duan J; Zhu Y; Zhang R
J Pharm Pharmacol; 2018 Jun; 70(6):830-838. PubMed ID: 29574918
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
Wang F; Zhang C; Ge W; Zhang G
J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
